Steve Maxwell
About Steve Maxwell
Steve Maxwell is the Director of Bioanalysis at Bristol-Myers Squibb, with extensive experience in bioanalytical compliance, drug metabolism, and drug development.
Title: Director of Bioanalysis
Steve Maxwell is currently the Director of Bioanalysis at Bristol-Myers Squibb, located in Summit, NJ, United States. In this role, he oversees all bioanalytical activities, ensuring compliance with regulatory standards and maintaining high-throughput data quality.
Company: Bristol-Myers Squibb
Steve Maxwell is employed at Bristol-Myers Squibb, where he holds the position of Director of Bioanalysis. His responsibilities include overseeing and managing bioanalytical operations, especially focusing on both preclinical and clinical analytical areas relating to regulated bioanalysis for large and small molecules.
Previous Roles: Celgene
Prior to his current role, Steve Maxwell worked at Celgene as Director of Bioanalysis from 2015 to 2019. During this period, he was instrumental in improving and establishing business practices to ensure high-quality data in a regulated environment. Before this, he also served as Associate Director of Drug Metabolism and Pharmacokinetics (DMPK) at Celgene from 2011 to 2015.
Previous Roles: Merck Research Laboratories
Steve Maxwell worked at Merck Research Laboratories from 2008 to 2010 as Section Leader in Bioanalytics. In this capacity, he was responsible for ensuring compliance and high standards in bioanalytical processes and data management.
Previous Roles: Schering-Plough Research Institute
Steve Maxwell had a decade-long tenure at Schering-Plough Research Institute from 1998 to 2008, where he specialized in bioanalytical methods and managed various bioanalytics projects, contributing to key advancements in the field.
Previous Roles: Roche
At Roche, Steve Maxwell served as Principal Scientist from 1996 to 1998. His role involved pioneering work in the realm of molecular genetics and microbiology, contributing to significant scientific progress during his tenure.
Education: Colorado State University
Steve Maxwell obtained his Bachelor of Science degree in Biology/Physiology from Colorado State University, where he studied from 1978 to 1983. His undergraduate education laid the foundation for his extensive career in bioanalysis and molecular genetics.
Education: Rutgers University
Steve Maxwell furthered his education at Rutgers University, earning a Master of Science degree and a Ph.D. in Molecular Genetics & Microbiology. His advanced studies provided him with the expertise needed to excel in various roles within the bioanalytical field.
Expertise in Bioanalytical Compliance and Drug Development
Steve Maxwell has demonstrated significant expertise in bioanalytical compliance, small molecule analysis, biologics, and drug metabolism. His extensive experience includes managing outsourced bioanalysis at Contract Research Organizations (CROs) and specializing in process improvement and drug development.
Proven Track Record in Preclinical and Clinical Analytical Areas
Steve Maxwell has a proven track record in both preclinical and clinical analytical areas of regulated bioanalysis for large and small molecules. His successful management and improvement of business practices have ensured quality data in regulated environments throughout his career.